Moreover, a widespread multi-omics analysis in more than 32 cancer types from The Cancer Genome Atlas (TCGA) dataset identified a genomic signature of 11 genes, correlated with TMB, able to predict the response to immunotherapy, which included FAT1 and NOTCH2, both mutated in our patient’s tumor (49). Here, FAT1 is linked to neoplasm.